Novavax | NVAX - L'Utile Operativo





L'Utile Operativo Cambiamento Data
Adma Biologics USD 62.75M 11.74M 2025-12
Agenus USD 14.4M 19.26M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Cassava Sciences USD -13.55M 1.69M 2025-12
Geron USD -236K 10.55M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
MannKind USD -76.99M 7.75M 2026-03
Merck USD -1.88B 8.12B 2026-03
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Moderna USD -1.39B 531M 2026-03
Novartis USD 4.06B 521M 2025-12
Novavax USD 20.94M 100.32M 2025-12
Pfizer USD 4.99B 340M 2026-03
Sanofi EUR 1.94B 239M 2026-03
Sarepta Therapeutics USD 358.43M 768.52M 2026-03
TG Therapeutics USD 34.8M 15.7M 2026-03